Article Information
History
- November 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Sidhartha Chaudhury1,
- Randall S. MacGill2,
- Angela M. Early3,
- Jessica S. Bolton4,
- C. Richter King2,
- Emily Locke2,
- Tony Pierson4,
- Dyann F. Wirth3,
- Daniel E. Neafsey3 and
- Elke S. Bergmann-Leitner4,*
- 1Center for Enabling Capabilities, WRAIR, Silver Spring, MD 20910
- 2PATH’s Malaria Vaccine Initiative, Washington, DC 20001, USA
- 3Broad Institute of MIT and Harvard T.H. Chan School of Public Health, Cambridge, MA 02142
- 4Immunology Core, Malaria Biologics Branch, WRAIR, Silver Spring, MD 20910
- ↵*Corresponding author: Elke S. Bergmann-Leitner, MSc PhD, email; elke.s.bergmann-leitner.civ{at}mail.mil
Posted November 16, 2020.
Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine
